The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio ... including life sciences research tools, kits and reagents; discovery of novel targets for ...

ErlySign’s innovation is a biomarker-based test kit capable of detecting oral precancerous conditions within just 15 minutes ...

To function through adulthood, permanent teeth need ongoing care, including brushing, flossing, and cleanings. Plus, dental ...

Healthtech startup ErlySign has raised Rs 16 crore ($1.8 million) in its pre-Series A round from Ashish Kacholia. Snippets ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's ...

Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing Market by Product & Service, by Application, by End-User, and By Region" report has been added to ResearchAndMarkets.com's ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "CRISPR-based Gene Editing market by Product & Service, by Application, by End-User, and By Region" report has been ...

According to the report, the CRISPR Genomic Cure Market will grow from US$ 3.18 Billion in 2023 to US$ 11.71 billion by 2030 at a compounded annual growth rate (CAGR) of 20.5% during the forecast ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...